New York City, New York Feb 23, 2021 (Issuewire.com) – Manhattan BioSolutions, Inc, an emerging biotechnology company focused on the discovery of immunoregulatory therapies for the treatment of metastatic cancers, today announced positive preclinical data from its in vivo efficacy study in a mouse model of bladder cancer. These data validate the key advantages […]